Frequencies for first 10,000 rows of indi_pt variable in indi2005q4 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABDOMINAL DISTENSION | 1 0.01 0.01 ABDOMINAL PAIN | 7 0.07 0.08 ABDOMINAL PAIN UPPER | 1 0.01 0.09 ABDOMINAL SYMPTOM | 2 0.02 0.11 ABNORMAL BEHAVIOUR | 4 0.04 0.15 ABORTION INDUCED | 2 0.02 0.17 ABSCESS | 2 0.02 0.19 ABSCESS LIMB | 1 0.01 0.20 ACCIDENT | 1 0.01 0.21 ACCIDENTAL EXPOSURE | 10 0.10 0.31 ACNE | 39 0.39 0.70 ACQUIRED IMMUNODEFICIENCY SYNDROME | 38 0.38 1.08 ACROMEGALY | 1 0.01 1.09 ACTINIC KERATOSIS | 1 0.01 1.10 ACUTE CORONARY SYNDROME | 8 0.08 1.18 ACUTE LEUKAEMIA | 1 0.01 1.19 ACUTE LYMPHOCYTIC LEUKAEMIA | 26 0.26 1.45 ACUTE MYELOID LEUKAEMIA | 19 0.19 1.64 ACUTE MYELOID LEUKAEMIA RECURRENT | 1 0.01 1.65 ACUTE MYOCARDIAL INFARCTION | 2 0.02 1.67 ACUTE PROMYELOCYTIC LEUKAEMIA | 6 0.06 1.73 ADENOCARCINOMA | 1 0.01 1.74 ADENOCARCINOMA PANCREAS | 5 0.05 1.79 ADRENAL INSUFFICIENCY | 1 0.01 1.80 ADVERSE EVENT | 7 0.07 1.87 AFFECT LABILITY | 1 0.01 1.88 AFFECTIVE DISORDER | 8 0.08 1.96 AGGRESSION | 2 0.02 1.98 AGITATION | 5 0.05 2.03 AKINESIA | 1 0.01 2.04 ALCOHOL POISONING | 1 0.01 2.05 ALCOHOL WITHDRAWAL SYNDROME | 1 0.01 2.06 ALCOHOLISM | 3 0.03 2.09 ALLERGIC SINUSITIS | 1 0.01 2.10 ALLERGY TO ARTHROPOD STING | 1 0.01 2.11 ALOPECIA | 8 0.08 2.19 AMYLOIDOSIS | 2 0.02 2.21 AMYOTROPHIC LATERAL SCLEROSIS | 1 0.01 2.22 ANAEMIA | 15 0.15 2.37 ANAEMIA MACROCYTIC | 2 0.02 2.39 ANAEMIA OF MALIGNANT DISEASE | 7 0.07 2.46 ANAESTHESIA | 21 0.21 2.67 ANAL CANCER | 8 0.08 2.75 ANALGESIC EFFECT | 12 0.12 2.87 ANALGESIC THERAPY | 2 0.02 2.89 ANAPLASTIC ASTROCYTOMA | 2 0.02 2.91 ANEURYSM | 1 0.01 2.92 ANGINA PECTORIS | 23 0.23 3.15 ANGINA UNSTABLE | 1 0.01 3.16 ANGIOGRAM | 1 0.01 3.17 ANGIOPATHY | 3 0.03 3.20 ANKLE FRACTURE | 2 0.02 3.22 ANKLE OPERATION | 1 0.01 3.23 ANKYLOSING SPONDYLITIS | 20 0.20 3.43 ANOREXIA | 2 0.02 3.45 ANTI-INFECTIVE THERAPY | 1 0.01 3.46 ANTIANDROGEN THERAPY | 1 0.01 3.47 ANTIBIOTIC LEVEL | 1 0.01 3.48 ANTIBIOTIC PROPHYLAXIS | 9 0.09 3.57 ANTICOAGULANT THERAPY | 12 0.12 3.69 ANTIDEPRESSANT THERAPY | 1 0.01 3.70 ANTIEMETIC SUPPORTIVE CARE | 3 0.03 3.73 ANTIFUNGAL PROPHYLAXIS | 1 0.01 3.74 ANTIINFLAMMATORY THERAPY | 3 0.03 3.77 ANTIPLATELET THERAPY | 2 0.02 3.79 ANTIPYRESIS | 1 0.01 3.80 ANTIVIRAL PROPHYLAXIS | 5 0.05 3.85 ANXIETY | 74 0.74 4.59 ANXIETY DISORDER | 9 0.09 4.68 AORTIC VALVE DISEASE | 1 0.01 4.69 AORTIC VALVE REPLACEMENT | 6 0.06 4.75 AORTIC VALVE STENOSIS | 1 0.01 4.76 APHASIA | 1 0.01 4.77 APLASTIC ANAEMIA | 3 0.03 4.80 ARRHYTHMIA | 9 0.09 4.89 ARRHYTHMIA PROPHYLAXIS | 1 0.01 4.90 ARTERIAL BYPASS OPERATION | 2 0.02 4.92 ARTERIOSCLEROSIS | 3 0.03 4.95 ARTERIOSCLEROSIS CORONARY ARTERY | 6 0.06 5.01 ARTERIOSCLEROSIS OBLITERANS | 5 0.05 5.06 ARTHRALGIA | 101 1.01 6.07 ARTHRITIS | 218 2.18 8.25 ARTHRITIS INFECTIVE | 1 0.01 8.26 ARTHROPATHY | 5 0.05 8.31 ARTHROPOD STING | 3 0.03 8.34 ARTHROSCOPY | 1 0.01 8.35 ASCITES INFECTION | 2 0.02 8.37 ASPERGILLOMA | 1 0.01 8.38 ASPERGILLOSIS | 8 0.08 8.46 ASPIRATION | 2 0.02 8.48 ASTHENOPIA | 1 0.01 8.49 ASTHMA | 130 1.30 9.79 ASTROCYTOMA | 1 0.01 9.80 ATRIAL FIBRILLATION | 68 0.68 10.48 ATRIAL FLUTTER | 3 0.03 10.51 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 47 0.47 10.98 ATYPICAL MYCOBACTERIAL INFECTION | 1 0.01 10.99 AURA | 1 0.01 11.00 AUTISM | 2 0.02 11.02 AUTISM SPECTRUM DISORDER | 1 0.01 11.03 AUTOIMMUNE HEPATITIS | 1 0.01 11.04 AUTOIMMUNE THYROIDITIS | 2 0.02 11.06 AUTONOMIC NERVOUS SYSTEM IMBALANCE | 1 0.01 11.07 B-CELL LYMPHOMA | 11 0.11 11.18 BACK DISORDER | 3 0.03 11.21 BACK INJURY | 4 0.04 11.25 BACK PAIN | 60 0.60 11.85 BACTERAEMIA | 2 0.02 11.87 BACTERIAL CULTURE POSITIVE | 1 0.01 11.88 BACTERIAL INFECTION | 1 0.01 11.89 BACTERIAL SEPSIS | 1 0.01 11.90 BASAL CELL CARCINOMA | 1 0.01 11.91 BEHCET'S SYNDROME | 2 0.02 11.93 BENIGN PROSTATIC HYPERPLASIA | 25 0.25 12.18 BILIARY NEOPLASM | 6 0.06 12.24 BIOPSY PROSTATE | 1 0.01 12.25 BIPOLAR DISORDER | 66 0.66 12.91 BIPOLAR I DISORDER | 14 0.14 13.05 BLADDER CANCER | 13 0.13 13.18 BLADDER DISORDER | 5 0.05 13.23 BLOOD CHOLESTEROL | 13 0.13 13.36 BLOOD CHOLESTEROL ABNORMAL | 1 0.01 13.37 BLOOD CHOLESTEROL INCREASED | 83 0.83 14.20 BLOOD CORTICOTROPHIN DECREASED | 1 0.01 14.21 BLOOD CORTISOL DECREASED | 1 0.01 14.22 BLOOD GLUCOSE INCREASED | 1 0.01 14.23 BLOOD IRON INCREASED | 1 0.01 14.24 BLOOD PHOSPHORUS | 1 0.01 14.25 BLOOD PHOSPHORUS INCREASED | 1 0.01 14.26 BLOOD PRESSURE | 17 0.17 14.43 BLOOD PRESSURE ABNORMAL | 1 0.01 14.44 BLOOD PRESSURE INADEQUATELY CONTROLLED | 1 0.01 14.45 BLOOD PRESSURE INCREASED | 10 0.10 14.55 BLOOD PROLACTIN INCREASED | 1 0.01 14.56 BLOOD TESTOSTERONE DECREASED | 1 0.01 14.57 BLOOD TRIGLYCERIDES INCREASED | 3 0.03 14.60 BODY HEIGHT BELOW NORMAL | 2 0.02 14.62 BONE DENSITY DECREASED | 1 0.01 14.63 BONE DISORDER | 7 0.07 14.70 BONE MARROW FAILURE | 1 0.01 14.71 BONE MARROW TRANSPLANT | 17 0.17 14.88 BONE PAIN | 4 0.04 14.92 BRADYCARDIA | 1 0.01 14.93 BRAIN NATRIURETIC PEPTIDE INCREASED | 1 0.01 14.94 BRAIN NEOPLASM | 8 0.08 15.02 BRAIN NEOPLASM MALIGNANT | 1 0.01 15.03 BRAIN OEDEMA | 1 0.01 15.04 BREAST CANCER | 105 1.05 16.09 BREAST CANCER FEMALE | 3 0.03 16.12 BREAST CANCER METASTATIC | 27 0.27 16.39 BREAST CANCER RECURRENT | 3 0.03 16.42 BREAST NEOPLASM | 1 0.01 16.43 BREAST OEDEMA | 1 0.01 16.44 BRONCHITIS | 30 0.30 16.74 BRONCHITIS ACUTE | 7 0.07 16.81 BRONCHITIS CHRONIC | 4 0.04 16.85 BRONCHOPNEUMOPATHY | 2 0.02 16.87 BRONCHOPULMONARY ASPERGILLOSIS | 4 0.04 16.91 BRONCHOSPASM | 2 0.02 16.93 BURNING SENSATION | 2 0.02 16.95 BURSITIS | 1 0.01 16.96 C-REACTIVE PROTEIN INCREASED | 1 0.01 16.97 CANCER PAIN | 18 0.18 17.15 CANDIDIASIS | 7 0.07 17.22 CANDIDURIA | 1 0.01 17.23 CARCINOID SYNDROME | 2 0.02 17.25 CARDIAC DISORDER | 7 0.07 17.32 CARDIAC FAILURE | 10 0.10 17.42 CARDIAC FAILURE CHRONIC | 5 0.05 17.47 CARDIAC FAILURE CONGESTIVE | 12 0.12 17.59 CARDIAC PACEMAKER INSERTION | 1 0.01 17.60 CARDIOMEGALY | 1 0.01 17.61 CARDIOMYOPATHY | 5 0.05 17.66 CARDIOPLEGIA | 1 0.01 17.67 CARDIOVASCULAR DISORDER | 10 0.10 17.77 CAROTID ARTERY STENOSIS | 2 0.02 17.79 CATAPLEXY | 3 0.03 17.82 CATARACT OPERATION | 1 0.01 17.83 CATHETERISATION CARDIAC | 1 0.01 17.84 CEREBRAL INFARCTION | 14 0.14 17.98 CEREBROVASCULAR ACCIDENT | 7 0.07 18.05 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 12 0.12 18.17 CEREBROVASCULAR DISORDER | 2 0.02 18.19 CERUMEN IMPACTION | 1 0.01 18.20 CERVICAL CORD COMPRESSION | 1 0.01 18.21 CERVIX CARCINOMA | 5 0.05 18.26 CHEMOTHERAPY | 9 0.09 18.35 CHEST DISCOMFORT | 1 0.01 18.36 CHEST PAIN | 8 0.08 18.44 CHOLANGITIS | 1 0.01 18.45 CHOLANGITIS SCLEROSING | 1 0.01 18.46 CHRONIC FATIGUE SYNDROME | 1 0.01 18.47 CHRONIC LYMPHOCYTIC LEUKAEMIA | 18 0.18 18.65 CHRONIC MYELOID LEUKAEMIA | 25 0.25 18.90 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 54 0.54 19.44 CLAVICLE FRACTURE | 1 0.01 19.45 CLOSTRIDIAL INFECTION | 1 0.01 19.46 CLOSTRIDIUM COLITIS | 1 0.01 19.47 CLUSTER HEADACHE | 1 0.01 19.48 COGNITIVE DISORDER | 2 0.02 19.50 COLD SWEAT | 1 0.01 19.51 COLITIS | 2 0.02 19.53 COLITIS ULCERATIVE | 9 0.09 19.62 COLON CANCER | 47 0.47 20.09 COLON CANCER METASTATIC | 13 0.13 20.22 COLORECTAL CANCER | 19 0.19 20.41 COLORECTAL CANCER METASTATIC | 34 0.34 20.75 COMPLETED SUICIDE | 1 0.01 20.76 COMPLEX PARTIAL SEIZURES | 6 0.06 20.82 COMPLEX REGIONAL PAIN SYNDROME | 3 0.03 20.85 COMPRESSION FRACTURE | 1 0.01 20.86 COMPUTERISED TOMOGRAM ABDOMEN | 3 0.03 20.89 COMPUTERISED TOMOGRAM HEAD | 1 0.01 20.90 CONDYLOMA ACUMINATUM | 1 0.01 20.91 CONFUSIONAL STATE | 2 0.02 20.93 CONGENITAL NEUROLOGICAL DISORDER | 1 0.01 20.94 CONGESTIVE CARDIOMYOPATHY | 1 0.01 20.95 CONSTIPATION | 34 0.34 21.29 CONSTIPATION PROPHYLAXIS | 1 0.01 21.30 CONTRACEPTION | 34 0.34 21.64 CONVULSION | 30 0.30 21.94 CONVULSION PROPHYLAXIS | 4 0.04 21.98 CORNEAL TRANSPLANT | 1 0.01 21.99 CORONARY ANGIOPLASTY | 4 0.04 22.03 CORONARY ARTERIAL STENT INSERTION | 3 0.03 22.06 CORONARY ARTERY DISEASE | 15 0.15 22.21 CORONARY ARTERY STENOSIS | 1 0.01 22.22 CORONARY ARTERY SURGERY | 3 0.03 22.25 COUGH | 11 0.11 22.36 CROHN'S DISEASE | 120 1.20 23.56 CRYING | 1 0.01 23.57 CYCLOTHYMIC DISORDER | 2 0.02 23.59 CYST | 1 0.01 23.60 CYSTINOSIS | 1 0.01 23.61 CYSTITIS | 4 0.04 23.65 CYSTITIS INTERSTITIAL | 1 0.01 23.66 CYTOMEGALOVIRUS CHORIORETINITIS | 6 0.06 23.72 CYTOMEGALOVIRUS INFECTION | 1 0.01 23.73 CYTOMEGALOVIRUS URINARY TRACT INFECTION | 1 0.01 23.74 DECREASED APPETITE | 1 0.01 23.75 DEEP VEIN THROMBOSIS | 12 0.12 23.87 DELUSION | 3 0.03 23.90 DELUSIONAL DISORDER, PERSECUTORY TYPE | 1 0.01 23.91 DEMENTIA | 16 0.16 24.07 DEMENTIA ALZHEIMER'S TYPE | 11 0.11 24.18 DENTAL DISORDER PROPHYLAXIS | 6 0.06 24.24 DENTAL TREATMENT | 1 0.01 24.25 DEPRESSION | 230 2.30 26.55 DEPRESSION POSTOPERATIVE | 1 0.01 26.56 DERMATITIS | 5 0.05 26.61 DERMATITIS ALLERGIC | 1 0.01 26.62 DERMATITIS ATOPIC | 6 0.06 26.68 DERMATITIS DIAPER | 1 0.01 26.69 DIABETES INSIPIDUS | 1 0.01 26.70 DIABETES MELLITUS | 211 2.11 28.81 DIABETES MELLITUS INSULIN-DEPENDENT | 32 0.32 29.13 DIABETES MELLITUS MALNUTRITION-RELATED | 1 0.01 29.14 DIABETES MELLITUS MANAGEMENT | 3 0.03 29.17 DIABETES MELLITUS NON-INSULIN-DEPENDENT | 93 0.93 30.10 DIABETIC FOOT INFECTION | 1 0.01 30.11 DIABETIC KETOACIDOSIS | 1 0.01 30.12 DIABETIC NEPHROPATHY | 1 0.01 30.13 DIABETIC NEUROPATHY | 3 0.03 30.16 DIAGNOSTIC PROCEDURE | 2 0.02 30.18 DIALYSIS | 6 0.06 30.24 DIARRHOEA | 6 0.06 30.30 DIFFUSE LARGE B-CELL LYMPHOMA | 25 0.25 30.55 DISEASE PROGRESSION | 1 0.01 30.56 DISSEMINATED INTRAVASCULAR COAGULATION | 3 0.03 30.59 DIURETIC THERAPY | 7 0.07 30.66 DIZZINESS | 3 0.03 30.69 DRUG ABUSER | 1 0.01 30.70 DRUG DEPENDENCE | 3 0.03 30.73 DRUG EXPOSURE DURING PREGNANCY | 1 0.01 30.74 DRUG THERAPY | 4 0.04 30.78 DRUG USE FOR UNKNOWN INDICATION | 802 8.02 38.80 DRUG WITHDRAWAL SYNDROME | 1 0.01 38.81 DRY MOUTH | 1 0.01 38.82 DRY SKIN | 2 0.02 38.84 DUODENAL ULCER | 2 0.02 38.86 DYSGEUSIA | 1 0.01 38.87 DYSLIPIDAEMIA | 12 0.12 38.99 DYSMENORRHOEA | 2 0.02 39.01 DYSPAREUNIA | 1 0.01 39.02 DYSPEPSIA | 12 0.12 39.14 DYSPNOEA | 2 0.02 39.16 DYSTHYMIC DISORDER | 4 0.04 39.20 DYSURIA | 2 0.02 39.22 EAR INFECTION | 1 0.01 39.23 ECZEMA | 2 0.02 39.25 ELECTROLYTE IMBALANCE | 1 0.01 39.26 EMBOLISM | 1 0.01 39.27 EMOTIONAL DISORDER | 1 0.01 39.28 EMPHYSEMA | 8 0.08 39.36 EMPYEMA | 1 0.01 39.37 ENDOCARDITIS | 6 0.06 39.43 ENDOCARDITIS BACTERIAL | 2 0.02 39.45 ENDODONTIC PROCEDURE | 1 0.01 39.46 ENDOMETRIAL CANCER | 3 0.03 39.49 ENDOMETRIOSIS | 1 0.01 39.50 ENTEROCOCCAL INFECTION | 2 0.02 39.52 EPICONDYLITIS | 2 0.02 39.54 EPIDIDYMITIS | 1 0.01 39.55 EPIDURAL ANAESTHESIA | 6 0.06 39.61 EPILEPSY | 65 0.65 40.26 EPSTEIN-BARR VIRUS INFECTION | 4 0.04 40.30 ERECTILE DYSFUNCTION | 34 0.34 40.64 ERYSIPELAS | 8 0.08 40.72 ERYTHEMA NODOSUM | 1 0.01 40.73 ESSENTIAL HYPERTENSION | 11 0.11 40.84 ESSENTIAL THROMBOCYTHAEMIA | 2 0.02 40.86 EUPHORIC MOOD | 2 0.02 40.88 EUSTACHIAN TUBE DYSFUNCTION | 1 0.01 40.89 EVAN'S SYNDROME | 1 0.01 40.90 EXCITABILITY | 2 0.02 40.92 EXTRAPYRAMIDAL DISORDER | 1 0.01 40.93 EXTRASYSTOLES | 1 0.01 40.94 EXTREMITY NECROSIS | 1 0.01 40.95 EYELID OEDEMA | 1 0.01 40.96 FABRY'S DISEASE | 1 0.01 40.97 FACIAL NERVE DISORDER | 1 0.01 40.98 FACIAL PAIN | 6 0.06 41.04 FACIAL SPASM | 10 0.10 41.14 FACTOR VIII DEFICIENCY | 2 0.02 41.16 FAECES HARD | 1 0.01 41.17 FALL | 1 0.01 41.18 FAMILIAL MEDITERRANEAN FEVER | 1 0.01 41.19 FATIGUE | 1 0.01 41.20 FEAR | 1 0.01 41.21 FEBRILE CONVULSION | 2 0.02 41.23 FEBRILE NEUTROPENIA | 2 0.02 41.25 FELTY'S SYNDROME | 1 0.01 41.26 FIBROMYALGIA | 19 0.19 41.45 FLATULENCE | 2 0.02 41.47 FLUID RETENTION | 6 0.06 41.53 FOLATE DEFICIENCY | 1 0.01 41.54 FOLLICULITIS | 2 0.02 41.56 FOOT FRACTURE | 1 0.01 41.57 FRACTURE | 1 0.01 41.58 FRONTAL LOBE EPILEPSY | 1 0.01 41.59 FUNGAEMIA | 1 0.01 41.60 FUNGAL INFECTION | 13 0.13 41.73 FUNGAL RASH | 1 0.01 41.74 FURUNCLE | 2 0.02 41.76 GAMMOPATHY | 2 0.02 41.78 GASTRIC CANCER | 14 0.14 41.92 GASTRIC DISORDER | 3 0.03 41.95 GASTRIC PH DECREASED | 1 0.01 41.96 GASTRIC PH INCREASED | 1 0.01 41.97 GASTRIC ULCER | 17 0.17 42.14 GASTRIC ULCER HAEMORRHAGE | 1 0.01 42.15 GASTRITIS | 27 0.27 42.42 GASTROINTESTINAL DISORDER | 8 0.08 42.50 GASTROINTESTINAL DISORDER THERAPY | 1 0.01 42.51 GASTROINTESTINAL HAEMORRHAGE | 3 0.03 42.54 GASTROINTESTINAL STROMAL TUMOUR | 1 0.01 42.55 GASTROINTESTINAL ULCER | 1 0.01 42.56 GASTROOESOPHAGEAL REFLUX DISEASE | 25 0.25 42.81 GAUCHER'S DISEASE | 2 0.02 42.83 GENERAL ANAESTHESIA | 18 0.18 43.01 GENERALISED ANXIETY DISORDER | 1 0.01 43.02 GERM CELL CANCER | 5 0.05 43.07 GLAUCOMA | 12 0.12 43.19 GLIOBLASTOMA | 6 0.06 43.25 GLIOBLASTOMA MULTIFORME | 22 0.22 43.47 GLIOMA | 1 0.01 43.48 GLIOSARCOMA | 1 0.01 43.49 GLOMERULONEPHRITIS MEMBRANOUS | 2 0.02 43.51 GLUCOSE TOLERANCE IMPAIRED | 5 0.05 43.56 GOUT | 24 0.24 43.80 GRAFT INFECTION | 1 0.01 43.81 GRAFT VERSUS HOST DISEASE | 5 0.05 43.86 GRAND MAL CONVULSION | 1 0.01 43.87 GROWTH HORMONE DEFICIENCY | 4 0.04 43.91 GROWTH RETARDATION | 1 0.01 43.92 GYNAECOMASTIA | 1 0.01 43.93 HAEMOGLOBIN DECREASED | 1 0.01 43.94 HAEMOLYTIC URAEMIC SYNDROME | 3 0.03 43.97 HAEMOPHILIA | 3 0.03 44.00 HAEMOPHILIC ARTHROPATHY | 1 0.01 44.01 HAEMORRHAGE | 1 0.01 44.02 HAEMORRHAGE CONTROL | 1 0.01 44.03 HAEMORRHAGIC DISORDER | 1 0.01 44.04 HAEMORRHOIDS | 1 0.01 44.05 HALLUCINATION | 6 0.06 44.11 HEADACHE | 14 0.14 44.25 HEART DISEASE CONGENITAL | 1 0.01 44.26 HEART RATE IRREGULAR | 2 0.02 44.28 HEART TRANSPLANT | 2 0.02 44.30 HEART VALVE REPLACEMENT | 2 0.02 44.32 HELICOBACTER INFECTION | 8 0.08 44.40 HENOCH-SCHONLEIN PURPURA | 1 0.01 44.41 HEPARIN-INDUCED THROMBOCYTOPENIA | 2 0.02 44.43 HEPATIC CIRRHOSIS | 6 0.06 44.49 HEPATIC FUNCTION ABNORMAL | 4 0.04 44.53 HEPATIC NEOPLASM MALIGNANT | 2 0.02 44.55 HEPATIC STEATOSIS | 1 0.01 44.56 HEPATITIS | 1 0.01 44.57 HEPATITIS B | 6 0.06 44.63 HEPATITIS C | 102 1.02 45.65 HEPATITIS C VIRUS | 2 0.02 45.67 HEPATITIS CHOLESTATIC | 1 0.01 45.68 HEPATITIS D | 1 0.01 45.69 HERPES SIMPLEX | 1 0.01 45.70 HERPES VIRUS INFECTION | 1 0.01 45.71 HERPES ZOSTER | 15 0.15 45.86 HIATUS HERNIA | 1 0.01 45.87 HICCUPS | 1 0.01 45.88 HIGH DENSITY LIPOPROTEIN ABNORMAL | 1 0.01 45.89 HIP ARTHROPLASTY | 3 0.03 45.92 HISTIOCYTOSIS HAEMATOPHAGIC | 2 0.02 45.94 HIV INFECTION | 423 4.23 50.17 HIV TEST POSITIVE | 6 0.06 50.23 HODGKIN'S DISEASE | 8 0.08 50.31 HORMONE LEVEL ABNORMAL | 1 0.01 50.32 HORMONE REPLACEMENT THERAPY | 165 1.65 51.97 HOT FLUSH | 4 0.04 52.01 HOUSE DUST ALLERGY | 2 0.02 52.03 HYPERAMMONAEMIA | 2 0.02 52.05 HYPERCALCAEMIA | 3 0.03 52.08 HYPERCALCAEMIA OF MALIGNANCY | 2 0.02 52.10 HYPERCHOLESTEROLAEMIA | 57 0.57 52.67 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCL.. | 1 0.01 52.68 HYPERGLYCAEMIA | 5 0.05 52.73 HYPERKALAEMIA | 3 0.03 52.76 HYPERLIPIDAEMIA | 63 0.63 53.39 HYPERPARATHYROIDISM SECONDARY | 7 0.07 53.46 HYPERPHOSPHATAEMIA | 7 0.07 53.53 HYPERPROLACTINAEMIA | 3 0.03 53.56 HYPERPYREXIA | 2 0.02 53.58 HYPERSENSITIVITY | 19 0.19 53.77 HYPERTENSION | 562 5.62 59.39 HYPERTHYROIDISM | 2 0.02 59.41 HYPERTONIC BLADDER | 7 0.07 59.48 HYPERTRIGLYCERIDAEMIA | 2 0.02 59.50 HYPERURICAEMIA | 8 0.08 59.58 HYPERVENTILATION | 1 0.01 59.59 HYPOAESTHESIA | 1 0.01 59.60 HYPOKALAEMIA | 1 0.01 59.61 HYPOMAGNESAEMIA | 2 0.02 59.63 HYPOMANIA | 2 0.02 59.65 HYPONATRAEMIA | 1 0.01 59.66 HYPOPHARYNGEAL CANCER RECURRENT | 3 0.03 59.69 HYPOPITUITARISM | 5 0.05 59.74 HYPOTHALAMO-PITUITARY DISORDERS | 1 0.01 59.75 HYPOTHYROIDISM | 34 0.34 60.09 HYPOTONIA | 2 0.02 60.11 IDIOPATHIC PULMONARY FIBROSIS | 1 0.01 60.12 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 7 0.07 60.19 ILL-DEFINED DISORDER | 275 2.75 62.94 IMMUNISATION | 11 0.11 63.05 IMMUNODEFICIENCY | 1 0.01 63.06 IMMUNODEFICIENCY COMMON VARIABLE | 1 0.01 63.07 IMMUNOSUPPRESSANT DRUG THERAPY | 4 0.04 63.11 IMMUNOSUPPRESSION | 4 0.04 63.15 IMPAIRED GASTRIC EMPTYING | 2 0.02 63.17 IMPETIGO | 1 0.01 63.18 INCORRECT DOSE ADMINISTERED | 2 0.02 63.20 INCREASED APPETITE | 1 0.01 63.21 INDUCTION OF ANAESTHESIA | 2 0.02 63.23 INFARCTION | 3 0.03 63.26 INFECTION | 27 0.27 63.53 INFECTION PROPHYLAXIS | 14 0.14 63.67 INFERTILITY FEMALE | 1 0.01 63.68 INFLAMMATION | 14 0.14 63.82 INFLAMMATORY CARCINOMA OF THE BREAST | 1 0.01 63.83 INFLUENZA | 2 0.02 63.85 INFLUENZA LIKE ILLNESS | 1 0.01 63.86 INJURY | 2 0.02 63.88 INSOMNIA | 73 0.73 64.61 INSULIN RESISTANCE | 1 0.01 64.62 INSULIN-REQUIRING TYPE II DIABETES ME.. | 10 0.10 64.72 INTENTIONAL DRUG MISUSE | 16 0.16 64.88 INTERMITTENT CLAUDICATION | 1 0.01 64.89 INTERNATIONAL NORMALISED RATIO DECREA.. | 1 0.01 64.90 INTERSTITIAL LUNG DISEASE | 2 0.02 64.92 INTERVERTEBRAL DISC DEGENERATION | 3 0.03 64.95 INTERVERTEBRAL DISC DISORDER | 1 0.01 64.96 INTERVERTEBRAL DISC PROTRUSION | 5 0.05 65.01 INTESTINAL FUNCTIONAL DISORDER | 1 0.01 65.02 INTRACRANIAL PRESSURE INCREASED | 1 0.01 65.03 INTRAOCULAR PRESSURE INCREASED | 5 0.05 65.08 INTUBATION | 1 0.01 65.09 IRON DEFICIENCY | 2 0.02 65.11 IRON DEFICIENCY ANAEMIA | 2 0.02 65.13 IRRITABILITY | 3 0.03 65.16 IRRITABLE BOWEL SYNDROME | 5 0.05 65.21 ISCHAEMIC CARDIOMYOPATHY | 6 0.06 65.27 JOINT ARTHROPLASTY | 1 0.01 65.28 JOINT INJURY | 2 0.02 65.30 JOINT SPRAIN | 1 0.01 65.31 JOINT STIFFNESS | 1 0.01 65.32 JOINT SWELLING | 1 0.01 65.33 JUVENILE ARTHRITIS | 4 0.04 65.37 JUVENILE CHRONIC MYELOMONOCYTIC LEUKA.. | 2 0.02 65.39 KERATOCONJUNCTIVITIS SICCA | 1 0.01 65.40 KNEE ARTHROPLASTY | 3 0.03 65.43 KNEE OPERATION | 1 0.01 65.44 KYPHOSCOLIOSIS | 2 0.02 65.46 LACRIMATION INCREASED | 1 0.01 65.47 LACTOSE INTOLERANCE | 1 0.01 65.48 LARYNGEAL CANCER | 2 0.02 65.50 LARYNGOPHARYNGITIS | 2 0.02 65.52 LAXATIVE SUPPORTIVE CARE | 2 0.02 65.54 LEFT VENTRICULAR FAILURE | 3 0.03 65.57 LEIOMYOMA | 1 0.01 65.58 LENTIGO MALIGNA STAGE UNSPECIFIED | 1 0.01 65.59 LEUKOCYTOSIS | 1 0.01 65.60 LICHEN PLANUS | 1 0.01 65.61 LIGAMENT INJURY | 2 0.02 65.63 LIMB CRUSHING INJURY | 1 0.01 65.64 LIMB INJURY | 4 0.04 65.68 LIMB OPERATION | 2 0.02 65.70 LIP AND/OR ORAL CAVITY CANCER RECURRENT | 1 0.01 65.71 LIPID METABOLISM DISORDER | 1 0.01 65.72 LIPIDS | 1 0.01 65.73 LIPIDS ABNORMAL | 1 0.01 65.74 LIPODYSTROPHY ACQUIRED | 1 0.01 65.75 LIVER DISORDER | 2 0.02 65.77 LIVER TRANSPLANT | 11 0.11 65.88 LOCAL ANAESTHESIA | 2 0.02 65.90 LOW DENSITY LIPOPROTEIN | 1 0.01 65.91 LOW DENSITY LIPOPROTEIN INCREASED | 2 0.02 65.93 LOWER LIMB FRACTURE | 2 0.02 65.95 LOWER RESPIRATORY TRACT INFECTION | 2 0.02 65.97 LUMBAR SPINAL STENOSIS | 1 0.01 65.98 LUNG ADENOCARCINOMA | 7 0.07 66.05 LUNG ADENOCARCINOMA METASTATIC | 2 0.02 66.07 LUNG CANCER METASTATIC | 6 0.06 66.13 LUNG CARCINOMA CELL TYPE UNSPECIFIED .. | 1 0.01 66.14 LUNG CARCINOMA CELL TYPE UNSPECIFIED .. | 1 0.01 66.15 LUNG CARCINOMA CELL TYPE UNSPECIFIED .. | 2 0.02 66.17 LUNG DISORDER | 7 0.07 66.24 LUNG INFECTION | 4 0.04 66.28 LUNG NEOPLASM MALIGNANT | 16 0.16 66.44 LUNG SQUAMOUS CELL CARCINOMA STAGE III | 3 0.03 66.47 LUNG SQUAMOUS CELL CARCINOMA STAGE UN.. | 5 0.05 66.52 LUNG TRANSPLANT | 1 0.01 66.53 LYME DISEASE | 1 0.01 66.54 LYMPHOMA | 24 0.24 66.78 MACULAR DEGENERATION | 8 0.08 66.86 MACULAR OEDEMA | 2 0.02 66.88 MAINTENANCE OF ANAESTHESIA | 1 0.01 66.89 MAJOR DEPRESSION | 9 0.09 66.98 MALABSORPTION | 2 0.02 67.00 MALARIA | 1 0.01 67.01 MALARIA PROPHYLAXIS | 9 0.09 67.10 MALIGNANT HYPERTENSION | 2 0.02 67.12 MALIGNANT MELANOMA | 7 0.07 67.19 MALIGNANT NEOPLASM OF RENAL PELVIS | 1 0.01 67.20 MALNUTRITION | 1 0.01 67.21 MANIA | 8 0.08 67.29 MANTLE CELL LYMPHOMA | 9 0.09 67.38 MEDICAL DIET | 4 0.04 67.42 MEMORY IMPAIRMENT | 2 0.02 67.44 MENIERE'S DISEASE | 2 0.02 67.46 MENINGITIS | 3 0.03 67.49 MENOPAUSAL SYMPTOMS | 19 0.19 67.68 MENOPAUSE | 5 0.05 67.73 MENORRHAGIA | 1 0.01 67.74 MENSTRUATION IRREGULAR | 2 0.02 67.76 MENTAL DISORDER | 5 0.05 67.81 MESOTHELIOMA | 2 0.02 67.83 METABOLIC DISORDER | 1 0.01 67.84 METASTASES TO BONE | 54 0.54 68.38 METASTASES TO CENTRAL NERVOUS SYSTEM | 3 0.03 68.41 METASTASES TO FALLOPIAN TUBE | 1 0.01 68.42 METASTASES TO LIVER | 1 0.01 68.43 METASTASES TO LUNG | 2 0.02 68.45 METASTASIS | 4 0.04 68.49 METASTATIC GASTRIC CANCER | 6 0.06 68.55 METASTATIC MALIGNANT MELANOMA | 5 0.05 68.60 METASTATIC RENAL CELL CARCINOMA | 4 0.04 68.64 MICROALBUMINURIA | 1 0.01 68.65 MICTURITION URGENCY | 2 0.02 68.67 MIGRAINE | 19 0.19 68.86 MIGRAINE PROPHYLAXIS | 4 0.04 68.90 MINERAL SUPPLEMENTATION | 7 0.07 68.97 MITRAL VALVE DISEASE | 1 0.01 68.98 MITRAL VALVE REPLACEMENT | 3 0.03 69.01 MIXED CONNECTIVE TISSUE DISEASE | 1 0.01 69.02 MIXED HYPERLIPIDAEMIA | 1 0.01 69.03 MOLLUSCUM CONTAGIOSUM | 1 0.01 69.04 MONARTHRITIS | 4 0.04 69.08 MOOD ALTERED | 1 0.01 69.09 MOOD SWINGS | 3 0.03 69.12 MORGANELLA INFECTION | 1 0.01 69.13 MUCORMYCOSIS | 1 0.01 69.14 MUCOSAL INFLAMMATION | 4 0.04 69.18 MULTIPLE ALLERGIES | 8 0.08 69.26 MULTIPLE MYELOMA | 87 0.87 70.13 MULTIPLE SCLEROSIS | 249 2.49 72.62 MUSCLE DISORDER | 1 0.01 72.63 MUSCLE MASS | 1 0.01 72.64 MUSCLE SPASMS | 14 0.14 72.78 MUSCLE SPASTICITY | 6 0.06 72.84 MUSCLE STRAIN | 2 0.02 72.86 MUSCLE TIGHTNESS | 1 0.01 72.87 MUSCULAR DYSTROPHY | 4 0.04 72.91 MUSCULOSKELETAL CHEST PAIN | 2 0.02 72.93 MUSCULOSKELETAL PAIN | 4 0.04 72.97 MUSCULOSKELETAL STIFFNESS | 1 0.01 72.98 MYALGIA | 4 0.04 73.02 MYASTHENIA GRAVIS | 1 0.01 73.03 MYASTHENIC SYNDROME | 1 0.01 73.04 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 6 0.06 73.10 MYELODYSPLASTIC SYNDROME | 9 0.09 73.19 MYELOPATHY | 1 0.01 73.20 MYOCARDIAL INFARCTION | 20 0.20 73.40 MYOCARDIAL ISCHAEMIA | 8 0.08 73.48 MYOCLONIC EPILEPSY | 2 0.02 73.50 MYOSITIS | 2 0.02 73.52 NAIL TINEA | 9 0.09 73.61 NARCOLEPSY | 2 0.02 73.63 NASAL CONGESTION | 2 0.02 73.65 NASAL POLYPS | 1 0.01 73.66 NASOPHARYNGEAL CANCER | 1 0.01 73.67 NASOPHARYNGITIS | 6 0.06 73.73 NAUSEA | 17 0.17 73.90 NECK INJURY | 3 0.03 73.93 NECK PAIN | 6 0.06 73.99 NEOPLASM | 7 0.07 74.06 NEOPLASM MALIGNANT | 7 0.07 74.13 NEOPLASM PROPHYLAXIS | 1 0.01 74.14 NEOPLASM PROSTATE | 1 0.01 74.15 NEPHROGENIC ANAEMIA | 1 0.01 74.16 NEPHROLITHIASIS | 1 0.01 74.17 NEPHROTIC SYNDROME | 7 0.07 74.24 NERVE COMPRESSION | 1 0.01 74.25 NERVE INJURY | 1 0.01 74.26 NERVOUS SYSTEM DISORDER | 1 0.01 74.27 NEURALGIA | 22 0.22 74.49 NEUROBLASTOMA | 3 0.03 74.52 NEUROENDOCRINE TUMOUR | 2 0.02 74.54 NEUROGENIC BLADDER | 1 0.01 74.55 NEUROPATHY | 8 0.08 74.63 NEUROPATHY PERIPHERAL | 7 0.07 74.70 NEUROPSYCHIATRIC LUPUS | 1 0.01 74.71 NEUTROPHIL COUNT DECREASED | 1 0.01 74.72 NOCTURIA | 1 0.01 74.73 NODAL ARRHYTHMIA | 2 0.02 74.75 NON-HODGKIN'S LYMPHOMA | 51 0.51 75.26 NON-SMALL CELL LUNG CANCER | 76 0.76 76.02 NON-SMALL CELL LUNG CANCER METASTATIC | 5 0.05 76.07 NON-SMALL CELL LUNG CANCER STAGE IIIB | 2 0.02 76.09 NON-SMALL CELL LUNG CANCER STAGE IV | 1 0.01 76.10 NUTRITIONAL SUPPORT | 2 0.02 76.12 OBESITY | 2 0.02 76.14 OBSESSIVE-COMPULSIVE DISORDER | 6 0.06 76.20 OBSTRUCTIVE AIRWAYS DISORDER | 2 0.02 76.22 OCULAR HYPERTENSION | 1 0.01 76.23 OEDEMA | 9 0.09 76.32 OEDEMA PERIPHERAL | 5 0.05 76.37 OESOPHAGEAL ADENOCARCINOMA | 1 0.01 76.38 OESOPHAGEAL CANCER METASTATIC | 4 0.04 76.42 OESOPHAGEAL CANDIDIASIS | 1 0.01 76.43 OESOPHAGEAL CARCINOMA | 9 0.09 76.52 OESOPHAGEAL CARCINOMA RECURRENT | 2 0.02 76.54 OESOPHAGEAL ULCER | 2 0.02 76.56 OESOPHAGITIS | 3 0.03 76.59 OESOPHAGOGASTROSCOPY | 1 0.01 76.60 OLIGODENDROGLIOMA | 4 0.04 76.64 OLIGURIA | 1 0.01 76.65 ONYCHOMYCOSIS | 16 0.16 76.81 OPEN ANGLE GLAUCOMA | 2 0.02 76.83 OPSOCLONUS MYOCLONUS | 2 0.02 76.85 ORAL CANDIDIASIS | 3 0.03 76.88 ORAL CONTRACEPTION | 10 0.10 76.98 ORGANIC ERECTILE DYSFUNCTION | 2 0.02 77.00 OSTEITIS DEFORMANS | 1 0.01 77.01 OSTEOARTHRITIS | 63 0.63 77.64 OSTEOMYELITIS | 2 0.02 77.66 OSTEOPENIA | 2 0.02 77.68 OSTEOPOROSIS | 102 1.02 78.70 OSTEOPOROSIS POSTMENOPAUSAL | 2 0.02 78.72 OSTEOPOROSIS PROPHYLAXIS | 5 0.05 78.77 OSTEOPOROTIC FRACTURE | 2 0.02 78.79 OTITIS EXTERNA | 1 0.01 78.80 OTITIS MEDIA | 1 0.01 78.81 OVARIAN CANCER | 13 0.13 78.94 OVARIAN EPITHELIAL CANCER | 2 0.02 78.96 OVARIAN EPITHELIAL CANCER RECURRENT | 1 0.01 78.97 OVARIAN FAILURE | 1 0.01 78.98 OVERDOSE | 1 0.01 78.99 OVULATION INDUCTION | 5 0.05 79.04 PAIN | 208 2.08 81.12 PAIN IN EXTREMITY | 17 0.17 81.29 PAIN IN JAW | 1 0.01 81.30 PAIN MANAGEMENT | 6 0.06 81.36 PAIN PROPHYLAXIS | 4 0.04 81.40 PANCREATIC CARCINOMA | 13 0.13 81.53 PANCREATIC CARCINOMA METASTATIC | 6 0.06 81.59 PANCREATIC CARCINOMA RECURRENT | 1 0.01 81.60 PANCREATIC CARCINOMA STAGE IV | 1 0.01 81.61 PANCREATIC INSUFFICIENCY | 1 0.01 81.62 PANCREATITIS CHRONIC | 1 0.01 81.63 PANIC ATTACK | 4 0.04 81.67 PANIC DISORDER | 6 0.06 81.73 PAPILLOEDEMA | 1 0.01 81.74 PARAESTHESIA | 1 0.01 81.75 PARANOIA | 1 0.01 81.76 PARKINSON'S DISEASE | 36 0.36 82.12 PARKINSONISM | 2 0.02 82.14 PARTIAL SEIZURES | 2 0.02 82.16 PATENT DUCTUS ARTERIOSUS | 1 0.01 82.17 PATHOGEN RESISTANCE | 1 0.01 82.18 PATIENT ISOLATION | 1 0.01 82.19 PELVIC PAIN | 1 0.01 82.20 PERIANAL ABSCESS | 1 0.01 82.21 PERIODONTITIS | 2 0.02 82.23 PERIPHERAL BLOOD STEM CELL APHERESIS | 3 0.03 82.26 PERIPHERAL CIRCULATORY FAILURE | 2 0.02 82.28 PERIPHERAL VASCULAR DISORDER | 2 0.02 82.30 PERITONEAL CARCINOMA | 2 0.02 82.32 PERONEAL MUSCULAR ATROPHY | 1 0.01 82.33 PERSONALITY DISORDER | 1 0.01 82.34 PETIT MAL EPILEPSY | 1 0.01 82.35 PHAEHYPHOMYCOSIS | 2 0.02 82.37 PHANTOM PAIN | 1 0.01 82.38 PHARYNGITIS | 7 0.07 82.45 PHARYNGOLARYNGEAL PAIN | 1 0.01 82.46 PHARYNGOTONSILLITIS | 2 0.02 82.48 PHIMOSIS | 1 0.01 82.49 PITUITARY TUMOUR BENIGN | 1 0.01 82.50 PLASMACYTOMA | 1 0.01 82.51 PLASMODIUM FALCIPARUM INFECTION | 1 0.01 82.52 PNEUMOCYSTIS JIROVECI PNEUMONIA | 5 0.05 82.57 PNEUMONIA | 41 0.41 82.98 PNEUMONIA ASPERGILLUS | 1 0.01 82.99 PNEUMONIA ASPIRATION | 3 0.03 83.02 PNEUMONIA BACTERIAL | 2 0.02 83.04 PNEUMONIA FUNGAL | 4 0.04 83.08 PNEUMONIA PRIMARY ATYPICAL | 3 0.03 83.11 PNEUMONIA STAPHYLOCOCCAL | 1 0.01 83.12 PNEUMONITIS | 3 0.03 83.15 POLLAKIURIA | 1 0.01 83.16 POLYARTHRITIS | 6 0.06 83.22 POLYCYSTIC OVARIES | 2 0.02 83.24 POLYCYTHAEMIA VERA | 1 0.01 83.25 POLYMYALGIA RHEUMATICA | 1 0.01 83.26 POLYNEUROPATHY | 2 0.02 83.28 POLYSUBSTANCE DEPENDENCE | 1 0.01 83.29 POLYURIA | 1 0.01 83.30 POOR PERIPHERAL CIRCULATION | 1 0.01 83.31 POST HERPETIC NEURALGIA | 2 0.02 83.33 POST PROCEDURAL COMPLICATION | 2 0.02 83.35 POST PROCEDURAL HAEMORRHAGE | 3 0.03 83.38 POST PROCEDURAL NAUSEA | 1 0.01 83.39 POST PROCEDURAL VOMITING | 1 0.01 83.40 POST-TRAUMATIC STRESS DISORDER | 6 0.06 83.46 POSTNASAL DRIP | 1 0.01 83.47 POSTOPERATIVE ABSCESS | 4 0.04 83.51 POSTOPERATIVE CARE | 1 0.01 83.52 POSTOPERATIVE INFECTION | 1 0.01 83.53 POSTPARTUM DEPRESSION | 3 0.03 83.56 POSTPARTUM HAEMORRHAGE | 1 0.01 83.57 PRADER-WILLI SYNDROME | 1 0.01 83.58 PRE-ECLAMPSIA | 1 0.01 83.59 PRE-EXISTING DISEASE | 1 0.01 83.60 PRECOCIOUS PUBERTY | 1 0.01 83.61 PREGNANCY | 2 0.02 83.63 PREMEDICATION | 28 0.28 83.91 PREOPERATIVE CARE | 2 0.02 83.93 PREPUCE REDUNDANT | 1 0.01 83.94 PRIMARY HYPERALDOSTERONISM | 1 0.01 83.95 PROCEDURAL HYPOTENSION | 1 0.01 83.96 PROCEDURAL PAIN | 8 0.08 84.04 PROPHYLACTIC CHEMOTHERAPY | 1 0.01 84.05 PROPHYLAXIS | 121 1.21 85.26 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 11 0.11 85.37 PROPHYLAXIS AGAINST SOLAR RADIATION | 1 0.01 85.38 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 24 0.24 85.62 PROPHYLAXIS OF NAUSEA AND VOMITING | 9 0.09 85.71 PROSTATE CANCER | 38 0.38 86.09 PROSTATE CANCER METASTATIC | 2 0.02 86.11 PROSTATE INFECTION | 2 0.02 86.13 PROSTATIC ADENOMA | 2 0.02 86.15 PROSTATISM | 2 0.02 86.17 PROSTATITIS | 3 0.03 86.20 PRURITUS | 8 0.08 86.28 PSEUDOMONAS INFECTION | 8 0.08 86.36 PSORIASIS | 30 0.30 86.66 PSORIATIC ARTHROPATHY | 10 0.10 86.76 PSYCHIATRIC SYMPTOM | 1 0.01 86.77 PSYCHOGENIC PAIN DISORDER | 1 0.01 86.78 PSYCHOMOTOR HYPERACTIVITY | 1 0.01 86.79 PSYCHOTIC DISORDER | 22 0.22 87.01 PULMONARY CONGESTION | 1 0.01 87.02 PULMONARY EMBOLISM | 14 0.14 87.16 PULMONARY HYPERTENSION | 12 0.12 87.28 PULMONARY MYCOSIS | 1 0.01 87.29 PULMONARY OEDEMA | 5 0.05 87.34 PULMONARY TUBERCULOSIS | 8 0.08 87.42 PURULENCE | 1 0.01 87.43 PYLORIC STENOSIS | 3 0.03 87.46 PYREXIA | 16 0.16 87.62 RADICULITIS LUMBOSACRAL | 1 0.01 87.63 RADICULOPATHY | 1 0.01 87.64 RADIOTHERAPY | 1 0.01 87.65 RASH | 9 0.09 87.74 RECTAL CANCER | 19 0.19 87.93 REFLUX OESOPHAGITIS | 6 0.06 87.99 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 2 0.02 88.01 RENAL CELL CARCINOMA STAGE UNSPECIFIED | 14 0.14 88.15 RENAL DISORDER | 2 0.02 88.17 RENAL FAILURE CHRONIC | 14 0.14 88.31 RENAL TRANSPLANT | 32 0.32 88.63 RESPIRATORY DEPRESSION | 1 0.01 88.64 RESPIRATORY DISORDER | 3 0.03 88.67 RESPIRATORY TRACT INFECTION | 2 0.02 88.69 RESTLESS LEGS SYNDROME | 11 0.11 88.80 RESTLESSNESS | 5 0.05 88.85 RETINAL ARTERY OCCLUSION | 1 0.01 88.86 RETINAL HAEMORRHAGE | 2 0.02 88.88 RETINAL OEDEMA | 3 0.03 88.91 RHESUS INCOMPATIBILITY | 1 0.01 88.92 RHEUMATIC FEVER | 1 0.01 88.93 RHEUMATOID ARTHRITIS | 416 4.16 93.09 RHINITIS | 2 0.02 93.11 RHINITIS ALLERGIC | 13 0.13 93.24 RHINITIS SEASONAL | 1 0.01 93.25 RHINORRHOEA | 2 0.02 93.27 RIB FRACTURE | 1 0.01 93.28 ROSACEA | 4 0.04 93.32 ROUTINE HEALTH MAINTENANCE | 4 0.04 93.36 SALIVARY GLAND CANCER | 1 0.01 93.37 SARCOIDOSIS | 6 0.06 93.43 SARCOMA | 13 0.13 93.56 SCAN | 1 0.01 93.57 SCAN WITH CONTRAST | 1 0.01 93.58 SCHIZOAFFECTIVE DISORDER | 11 0.11 93.69 SCHIZOPHRENIA | 47 0.47 94.16 SCHIZOPHRENIA, DISORGANISED TYPE | 1 0.01 94.17 SCHIZOPHRENIA, PARANOID TYPE | 2 0.02 94.19 SEASONAL ALLERGY | 5 0.05 94.24 SEBORRHOEIC DERMATITIS | 1 0.01 94.25 SECONDARY PROGRESSIVE MULTIPLE SCLERO.. | 4 0.04 94.29 SEDATION | 3 0.03 94.32 SEPSIS | 19 0.19 94.51 SEPTIC NECROSIS | 1 0.01 94.52 SEPTIC SHOCK | 8 0.08 94.60 SERUM SEROTONIN INCREASED | 1 0.01 94.61 SHOCK | 1 0.01 94.62 SHOULDER PAIN | 14 0.14 94.76 SHUNT STENOSIS | 1 0.01 94.77 SICK SINUS SYNDROME | 1 0.01 94.78 SIDEROBLASTIC ANAEMIA | 1 0.01 94.79 SILENT MYOCARDIAL INFARCTION | 1 0.01 94.80 SINUS DISORDER | 3 0.03 94.83 SINUS TACHYCARDIA | 1 0.01 94.84 SINUSITIS | 16 0.16 95.00 SINUSITIS ASPERGILLUS | 1 0.01 95.01 SKIN CHAPPED | 2 0.02 95.03 SKIN EXFOLIATION | 1 0.01 95.04 SKIN INFECTION | 2 0.02 95.06 SKIN LESION | 1 0.01 95.07 SKIN PAPILLOMA | 2 0.02 95.09 SKIN REACTION | 1 0.01 95.10 SKIN ULCER | 3 0.03 95.13 SKIN WRINKLING | 7 0.07 95.20 SLEEP APNOEA SYNDROME | 2 0.02 95.22 SLEEP DISORDER | 19 0.19 95.41 SLEEP DISORDER THERAPY | 2 0.02 95.43 SMALL CELL LUNG CANCER METASTATIC | 2 0.02 95.45 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 18 0.18 95.63 SMOKING CESSATION THERAPY | 11 0.11 95.74 SOCIAL PHOBIA | 3 0.03 95.77 SOMNOLENCE | 3 0.03 95.80 SPASTIC PARALYSIS | 2 0.02 95.82 SPINAL ANAESTHESIA | 8 0.08 95.90 SPINAL COLUMN STENOSIS | 1 0.01 95.91 SPINAL CORD COMPRESSION | 1 0.01 95.92 SPINAL FRACTURE | 1 0.01 95.93 SPINAL MUSCULAR ATROPHY | 1 0.01 95.94 SPINAL OSTEOARTHRITIS | 8 0.08 96.02 SPONDYLITIS | 5 0.05 96.07 SPUTUM RETENTION | 1 0.01 96.08 SQUAMOUS CELL CARCINOMA | 4 0.04 96.12 SQUAMOUS CELL CARCINOMA OF THE CERVIX | 2 0.02 96.14 STAPHYLOCOCCAL INFECTION | 6 0.06 96.20 STASIS DERMATITIS | 1 0.01 96.21 STATUS EPILEPTICUS | 10 0.10 96.31 STEM CELL TRANSPLANT | 18 0.18 96.49 STENT PLACEMENT | 3 0.03 96.52 STOMACH DISCOMFORT | 2 0.02 96.54 STOMATITIS | 2 0.02 96.56 STRESS | 5 0.05 96.61 STRESS FRACTURE | 1 0.01 96.62 STRIDOR | 1 0.01 96.63 SUBDURAL HAEMATOMA | 1 0.01 96.64 SUBILEUS | 1 0.01 96.65 SUICIDE ATTEMPT | 54 0.54 97.19 SUNBURN | 1 0.01 97.20 SUPRAVENTRICULAR TACHYCARDIA | 2 0.02 97.22 SURGERY | 1 0.01 97.23 SWELLING | 1 0.01 97.24 SWELLING FACE | 1 0.01 97.25 SYPHILIS | 1 0.01 97.26 SYSTEMIC ANTIBACTERIAL THERAPY | 2 0.02 97.28 SYSTEMIC CANDIDA | 3 0.03 97.31 SYSTEMIC LUPUS ERYTHEMATOSUS | 14 0.14 97.45 T-CELL LYMPHOMA | 5 0.05 97.50 TACHYARRHYTHMIA | 2 0.02 97.52 TACHYCARDIA | 4 0.04 97.56 TAKAYASU'S ARTERITIS | 1 0.01 97.57 TEMPORAL ARTERITIS | 2 0.02 97.59 TEMPORAL LOBE EPILEPSY | 3 0.03 97.62 TENDONITIS | 2 0.02 97.64 TENSION HEADACHE | 2 0.02 97.66 TESTICULAR NEOPLASM | 1 0.01 97.67 THALASSAEMIA | 1 0.01 97.68 THERAPEUTIC PROCEDURE | 2 0.02 97.70 THERAPEUTIC RESPONSE DECREASED | 1 0.01 97.71 THIRST | 1 0.01 97.72 THROMBOCYTHAEMIA | 3 0.03 97.75 THROMBOCYTOPENIA | 1 0.01 97.76 THROMBOSIS | 2 0.02 97.78 THROMBOSIS IN DEVICE | 5 0.05 97.83 THROMBOSIS PROPHYLAXIS | 57 0.57 98.40 THROMBOTIC THROMBOCYTOPENIC PURPURA | 3 0.03 98.43 THYROID DISORDER | 3 0.03 98.46 THYROIDECTOMY | 3 0.03 98.49 THYROXINE DECREASED | 1 0.01 98.50 TINEA BLANCA | 1 0.01 98.51 TINEA PEDIS | 1 0.01 98.52 TOBACCO ABUSE | 4 0.04 98.56 TONGUE CANCER METASTATIC | 3 0.03 98.59 TONSILLITIS | 3 0.03 98.62 TOOTH ABSCESS | 1 0.01 98.63 TOOTH EXTRACTION | 2 0.02 98.65 TOOTHACHE | 3 0.03 98.68 TORTICOLLIS | 5 0.05 98.73 TOXIC EPIDERMAL NECROLYSIS | 1 0.01 98.74 TRANSIENT ISCHAEMIC ATTACK | 4 0.04 98.78 TRANSITIONAL CELL CARCINOMA | 1 0.01 98.79 TRANSPLANT EVALUATION | 1 0.01 98.80 TRANSPLANT REJECTION | 2 0.02 98.82 TRAUMATIC HAEMORRHAGE | 1 0.01 98.83 TREMOR | 1 0.01 98.84 TRIGEMINAL NEURALGIA | 3 0.03 98.87 TUBERCULIN TEST | 4 0.04 98.91 TUBERCULOSIS | 3 0.03 98.94 TYPE IIA HYPERLIPIDAEMIA | 1 0.01 98.95 ULCER | 4 0.04 98.99 ULCERATIVE KERATITIS | 1 0.01 99.00 UNEVALUABLE EVENT | 1 0.01 99.01 UPPER RESPIRATORY TRACT INFECTION | 5 0.05 99.06 URETERIC CANCER | 2 0.02 99.08 URETHRAL DISORDER | 1 0.01 99.09 URINARY INCONTINENCE | 7 0.07 99.16 URINARY RETENTION | 3 0.03 99.19 URINARY TRACT DISORDER | 1 0.01 99.20 URINARY TRACT INFECTION | 19 0.19 99.39 URINE OUTPUT INCREASED | 1 0.01 99.40 URTICARIA | 2 0.02 99.42 UTERINE CANCER | 5 0.05 99.47 UVEITIS | 1 0.01 99.48 VAGINITIS BACTERIAL | 2 0.02 99.50 VASCULAR BYPASS GRAFT | 1 0.01 99.51 VASCULITIS CEREBRAL | 1 0.01 99.52 VASODILATATION | 3 0.03 99.55 VENOUS INSUFFICIENCY | 2 0.02 99.57 VENOUS THROMBOSIS | 1 0.01 99.58 VERTIGO | 1 0.01 99.59 VISUAL DISTURBANCE | 1 0.01 99.60 VITAMIN B12 DEFICIENCY | 2 0.02 99.62 VITAMIN SUPPLEMENTATION | 19 0.19 99.81 VOMITING | 4 0.04 99.85 VULVAL CANCER | 2 0.02 99.87 VULVOVAGINAL DRYNESS | 1 0.01 99.88 VULVOVAGINAL MYCOTIC INFECTION | 2 0.02 99.90 WALDENSTROM'S MACROGLOBULINAEMIA | 2 0.02 99.92 WEIGHT CONTROL | 2 0.02 99.94 WEIGHT DECREASED | 2 0.02 99.96 WHITE BLOOD CELL COUNT DECREASED | 1 0.01 99.97 WOUND INFECTION | 2 0.02 99.99 WOUND INFECTION STAPHYLOCOCCAL | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015